Author:
Kumar Ashutosh,Narayan Ravi K.,Kumari Chiman,Faiq Muneeb A.,Kulandhasamy Maheswari,Kant Kamla,Pareek Vikas
Reference42 articles.
1. COVID-19 and thrombotic or thromboembolic disease: implications for prevention, antithrombotic therapy, and follow-up: JACC state-of-the-art review;Bikdeli;J Am Coll Cardiol,2020
2. Ranucci M, Ballotta A, Di Dedda U. The procoagulant pattern of patients with COVID-19 acute respiratory distress syndrome [published online ahead of print 17 April 2020]. J Thromb Haemost.
3. Incidence of thrombotic complications in critically ill ICU patients with COVID-19;Klok;Thromb Res,2020
4. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia;Tang;J Thromb Haemost,2020
5. Sungnak W, Huang N, Bécavin C, Berg M, Queen R, Litvinukova M, Talavera-López C, Maatz H, Reichart D, Sampaziotis F, Worlock KB. SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes. Nature medicine. 2020 May;26(5):681-7.https://doi.org/10.1038/s41591-020-0868-6.
Cited by
61 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献